Showing 901 - 920 results of 109,804 for search '(( 20 c decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (we decrease)) ))', query time: 1.96s Refine Results
  1. 901

    Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

    Published 2009
    “…Curves represent mean change in optical density (OD) at 30-s intervals. (E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”
  2. 902
  3. 903
  4. 904

    Autocrine CXCL12 decreases cell adhesion of colorectal carcinoma cells. by Luke J. Drury (241337)

    Published 2010
    “…GAPDH expression served as a loading control. (B) HT29 cells cultured in complete medium exhibit decreased adhesion after 6-days in culture (D0, D2, D4, D5, D6) compared to control (GFP) cells by phase microscopy (10X). …”
  5. 905

    Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

    Published 2019
    “…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”
  6. 906
  7. 907
  8. 908
  9. 909
  10. 910
  11. 911
  12. 912
  13. 913
  14. 914
  15. 915

    <i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation. by Siyun Lee (17087351)

    Published 2025
    “…<b>(B)</b> ECE treatment decreases plaque formation in a dose-dependent manner. …”
  16. 916
  17. 917
  18. 918

    Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue by Elisabeth G. Hain (542261)

    Published 2016
    “…After treatment cessation, we observed opposed viscoelastic changes in the midbrain, hippocampus and SN with the midbrain showing a gradual rise and the hippocampus a distinct transient increase of viscous and elastic parameters, while viscosity and–to a lesser extent—elasticity in the SN decreased over time. …”
  19. 919

    The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

    Published 2013
    “…<p>Myocardium was treated with the estrogen receptor-α agonist PPT (100 nM) for 1 (A) (N = 9), 2.5 (B) (N = 9), or 5 min (C) (N = 22). …”
  20. 920